(Q36360319)

13 August 2017

1 reference

title

Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches (English)

1 reference

13 August 2017

0 references

Peter J Goadsby

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

13 August 2017

page(s)

2557-2567

1 reference

Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200565180-00002

Cerebrovascular responses to capsaicin in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200565180-00002

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200565180-00002

Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200565180-00002

A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200565180-00002

The diversity in the vanilloid (TRPV) receptor family of ion channels

21 January 2018

1 reference

12 December 2020

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine

1 reference

12 December 2020

Possible benefit of GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine

1 reference

12 December 2020

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

1 reference

12 December 2020

Co-localization of retrogradely transported wheat germ agglutinin and the putative neurotransmitter substance P within trigeminal ganglion cells projecting to cat middle cerebral artery

1 reference

12 December 2020

Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors

1 reference

12 December 2020

Facial flushing after thermocoagulation of the Gasserian ganglion

1 reference

12 December 2020

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

12 December 2020

2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study

1 reference

12 December 2020

Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain

1 reference

12 December 2020

Stimulation of the trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey

1 reference

12 December 2020

Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice

1 reference

12 December 2020

Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment

1 reference

12 December 2020

Cerebral vasodilation after the thermocoagulation of the trigeminal ganglion in humans

1 reference

12 December 2020

Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist

1 reference

12 December 2020

Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry.

1 reference

12 December 2020

Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks

1 reference

12 December 2020

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

1 reference

12 December 2020

Vascular and cellular responses to pro-inflammatory stimuli in rat dental pulp

1 reference

12 December 2020

Nitric oxide synthase inhibition in migraine

1 reference

12 December 2020

Calcitonin gene-related peptide: functional role in cerebrovascular regulation

1 reference

12 December 2020

Perivascular substance P: occurrence and distribution in mammalian pial vessels.

1 reference

12 December 2020

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

1 reference

12 December 2020

In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid

1 reference

12 December 2020

The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS blocks CGRP and adrenomedullin vasoactive responses in the microvasculature.

1 reference

12 December 2020

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

12 December 2020

Chronic trigeminal ganglionectomy or topical capsaicin application to pial vessels attenuates postocclusive cortical hyperemia but does not influence postischemic hypoperfusion

1 reference

12 December 2020

The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study

1 reference

12 December 2020

Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat.

1 reference

12 December 2020

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation

1 reference

12 December 2020

Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

1 reference

12 December 2020

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products

1 reference

12 December 2020

Topiramate inhibits trigeminovascular activation: an intravital microscopy study

1 reference

12 December 2020

RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks

1 reference

12 December 2020

Flunarizine in migraine: a minireview

1 reference

12 December 2020

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

1 reference

12 December 2020

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

1 reference

12 December 2020

Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally

1 reference

12 December 2020

Rizatriptan has central antinociceptive effects against durally evoked responses

1 reference

12 December 2020

The global burden of disease study: implications for neurology

1 reference

12 December 2020

Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation

1 reference

12 December 2020

The peripheral pathway for extracranial vasodilatation in the cat.

1 reference

12 December 2020

The effect of adrenergic compounds on neurogenic dural vasodilatation

1 reference

12 December 2020

The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.

1 reference

12 December 2020

Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies

1 reference

12 December 2020

Nitrolglycerin as a provocative agent in cluster headache

1 reference

12 December 2020

Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.

1 reference

12 December 2020

Pattern of intracranial and extracranial projections of trigeminal ganglion cells

1 reference

12 December 2020

Expression in brain of a messenger RNA encoding a novel neuropeptide homologous to calcitonin gene-related peptide

1 reference

12 December 2020

Ergotamine in the acute treatment of migraine: a review and European consensus

1 reference

12 December 2020

Radiofrequency percutaneous Gasserian ganglion lesions. Results in 140 patients with trigeminal pain

1 reference

12 December 2020

Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation

1 reference

12 December 2020

Controlled thermocoagulation of trigeminal ganglion and rootlets for differential destruction of pain fibers. 1. Trigeminal neuralgia.

1 reference

12 December 2020

Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine?

1 reference

12 December 2020

Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288

1 reference

12 December 2020

Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P.

1 reference

12 December 2020

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

12 December 2020

Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries

1 reference

12 December 2020

Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP).

1 reference

12 December 2020

Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.

1 reference

12 December 2020

Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.

1 reference

12 December 2020

Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack

1 reference

12 December 2020

Vascular actions of calcitonin gene-related peptide and adrenomedullin

1 reference

12 December 2020

5-HT(1A) and 5-HT(1B/1D) receptors are involved in the modulation of the trigeminovascular system of the cat: a microiontophoretic study

1 reference

12 December 2020

The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels

1 reference

12 December 2020

The tentorial nerves and Iocalization of intracranial pain in man

1 reference

12 December 2020

Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats

1 reference

12 December 2020

Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug

1 reference

12 December 2020

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

12 December 2020

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

1 reference

12 December 2020

Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats

1 reference

12 December 2020

Genetic and physical mapping of the human cannabinoid receptor gene to chromosome 6q14-q15

1 reference

12 December 2020

The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids

1 reference

12 December 2020

No acute antimigraine efficacy of CP-122,288, a highly potent inhibitor of neurogenic inflammation: results of two randomized, double-blind, placebo-controlled clinical trials

1 reference

12 December 2020

Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ

1 reference

12 December 2020

The assessment of vasoactive properties of CGRP and adrenomedullin in the microvasculature: a study using in vivo and in vitro assays in the mouse

1 reference

12 December 2020

Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat

1 reference

12 December 2020

Origin and distribution of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia investigated with retrograde and anterograde WGA-HRP tracing in the rat.

1 reference

12 December 2020

Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion

1 reference

12 December 2020

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study

1 reference

12 December 2020

Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides

1 reference

12 December 2020

4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses

1 reference

12 December 2020

Sumatriptan inhibits the release of CGRP and substance P from the rat spinal cord

1 reference

12 December 2020

Pia arachnoid contains substance P originating from trigeminal neurons

1 reference

12 December 2020

Lanepitant, an NK-1 antagonist, in migraine prevention

1 reference

12 December 2020

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

1 reference

12 December 2020

Vasodilator system for the face

1 reference

12 December 2020

Decreased carotid arterial resistance in cats in response to trigeminal stimulation

1 reference

12 December 2020

Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat.

1 reference

12 December 2020

Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat.

1 reference

12 December 2020

Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack

1 reference

12 December 2020

The pharmacology of headache

1 reference

12 December 2020

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

1 reference

12 December 2020

Substance P receptor antagonists in the therapy of migraine

1 reference

12 December 2020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

12 December 2020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

12 December 2020

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

1 reference

12 December 2020

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

12 December 2020

NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release

1 reference

12 December 2020

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

1 reference

12 December 2020

4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?

1 reference

12 December 2020

An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse.

1 reference

12 December 2020

Central projections of sensory innervation of the rat superficial temporal artery.

1 reference

12 December 2020

The role of histamine in dural vessel dilation

1 reference

12 December 2020

Migraine--current understanding and treatment

1 reference

12 December 2020

The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system

1 reference

12 December 2020

Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow

1 reference

12 December 2020

Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater.

1 reference

12 December 2020

The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation

1 reference

12 December 2020

Capsaicin receptor immunoreactivity in the human trigeminal ganglion.

1 reference

12 December 2020

Glyceryl trinitrate triggers premonitory symptoms in migraineurs

1 reference

12 December 2020

Trigeminovascular fibers increase blood flow in cortical gray matter by axon reflex-like mechanisms during acute severe hypertension or seizures

1 reference

12 December 2020

Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception

1 reference

12 December 2020

The mode of action of sumatriptan is vascular? A debate

1 reference

12 December 2020

Central projections of sensory innervation of the rat superior sagittal sinus.

1 reference

12 December 2020

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

1 reference

12 December 2020

10.2165/00003495-200565180-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

13 August 2017

1022486286

0 references

Fatcat ID

release_4wsxb6olarbprcsig7quynsabq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4wsxb6olarbprcsig7quynsabq

24 November 2022

mapped directly with Wikidata item

1 reference